ResApp Health Limited (RAP) 2017年年度报告「ASX」.pdf

1、 1 ResApp Health Limited ABN 51 094 468 318 CONSOLIDATED ANNUAL REPORT FOR THE YEAR ENDED 30 JUNE 2017 ResApp Health Limited Consolidated Annual Report ABN 51 094 468 318 Contents to the Consolidated Financial Report 2 Corporate Information.3 Directors Report.4 Auditors Independence Declaration.15 C

2、onsolidated Statement of Profit and Loss and Other Comprehensive Income for the financial year ended 30 June 2017 .16 Consolidated Statement of Financial Position as at 30 June 2017 .17 Consolidated Statement of Changes in Equity for the financial year ended 30 June 2017 .18 Consolidated Statement o

3、f Cash Flows for the financial year ended 30 June 2017 .19 Notes to the Consolidated Financial Statements.20 Directors Declaration.41 Independent Auditors Report.42 ASX Additional Information.46 ResApp Health Limited Consolidated Annual Report ABN 51 094 468 318 Corporate Information 3 This annual r

4、eport is for ResApp Health Limited and its controlled entity(“the Group”).Unless otherwise stated,all amounts are presented in Australian Dollars.A description of the Groups operations and of its principal activities is included in the review of operations and activities in the directors report on p

5、ages 6 to 9.The directors report is not part of the financial statements.Directors Dr Roger Aston(appointed 2 July 2015)Dr Tony Keating(appointed 2 July 2015)Mr Brian Leedman(appointed 19 February 2016)Mr Chris Ntoumenopoulos(appointed 21 January 2015)Company Secretary Ms Nicki Farley Principal Offi

6、ce Level 8,127 Creek St Brisbane QLD 4000 Auditors Grant Thornton Audit Pty Ltd Level 1,10 Kings Park Road WEST PERTH WA 6005 Solicitors Price Sierakowski Corporate Level 24,44 St Georges Tce PERTH WA 6000 Stock Exchange Listing ResApp Health Limited ASX Code:RAP Web Site .au Registered Office Level